The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
King's College London · South London and Maudsley NHS Foundation Trust · +20 more institutions
Abstract
Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of cannabis use with the strongest effect on odds of psychotic disorder across Europe and explore whether differences in such patterns contribute to variations in the incidence rates of psychotic disorder.
-tetrahydrocannabinol (THC) in the different types of cannabis available across the sites, we divided the types of cannabis used by participants into two categories: low potency (THC
Citation impact
- FWCI
- 81.32
- Percentile
- 100%
- References
- 33
Authors
87- MDMarta Di FortiCorresponding
King's College London, South London and Maudsley NHS Foundation Trust, National Institute for Health and Care Research, Mental Health Foundation
- DQDiego Quattrone
King's College London, South London and Maudsley NHS Foundation Trust, National Institute for Health and Care Research, Mental Health Foundation
- TPTom P. Freeman
University of Bath
- GTGiada Tripoli
King's College London
- CGCharlotte Gayer‐Anderson
King's College London
Topics & keywords
- Cannabis
- Incidence (geometry)
- Psychiatry
- Medicine
- Schizophrenia (object-oriented programming)
- MEDLINE
- Variation (astronomy)
- Psychology
- Good health and well-being
Funding
- SLSouth London and Maudsley NHS Foundation Trust
- SSunovion
- WTWellcome TrustAwards: 101272/Z/12/Z, grant 101272/Z/12/Z
- NINational Institute for Health and Care Research
- KCKing's College London
- UCUniversity College London
- FDFundação de Amparo à Pesquisa do Estado de São PauloAwards: 2012/0417-0, grant 2012/0417-0
- SServier
- CRCasen Recordati
- HLH. Lundbeck A/S
- SFSeventh Framework ProgrammeAward: HEALTH-F2-2009-241909
- MRMedical Research CouncilAward: MR/M008436/1